Mitchell Chan

Insider Reports History

Location
C/O Viela Bio, Inc., One Medimmune Way, First Floor, Area Two, Gaithersburg, MD
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mitchell Chan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Chief Financial Officer Common Stock 54K $482K $8.93 Sep 1, 2025 Direct
Avalo Therapeutics, Inc. Director Restricted Stock Units 6.33K $53.6K $8.46 Mar 28, 2025 Direct
Avalo Therapeutics, Inc. Director Common Stock 3.17K $26.8K $8.46 Mar 28, 2025 Direct
REGENXBIO Inc. Chief Financial Officer Stock Options (Right to buy) 62.5K Jan 2, 2025 Direct
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 20.1K Jun 17, 2025 Direct

Insider Reports Filed by Mitchell Chan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGNX REGENXBIO Inc. Sep 1, 2025 1 -$43.8K 4 Sep 3, 2025 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. Jun 17, 2025 1 $0 4 Jun 18, 2025 Director
AVTX Avalo Therapeutics, Inc. Mar 28, 2025 2 $0 4 Apr 1, 2025 Director
RGNX REGENXBIO Inc. Jan 2, 2025 1 $0 4 Jan 6, 2025 Chief Financial Officer
RGNX REGENXBIO Inc. Sep 16, 2024 2 $0 4 Sep 18, 2024 Chief Financial Officer
RGNX REGENXBIO Inc. Sep 16, 2024 0 $0 3 Sep 18, 2024 Chief Financial Officer
AVTX Avalo Therapeutics, Inc. Aug 13, 2024 2 $0 4 Aug 14, 2024 Director
AVTX Avalo Therapeutics, Inc. Dec 20, 2023 1 $0 4 Dec 21, 2023 Director
AVTX Avalo Therapeutics, Inc. Jun 14, 2022 1 $0 4 Jun 15, 2022 Director
AVTX Avalo Therapeutics, Inc. Dec 1, 2021 1 $0 4 Dec 3, 2021 Director
AVTX Avalo Therapeutics, Inc. Dec 1, 2021 0 $0 3 Dec 3, 2021 Director